City dodges bullet as HQ stays under Anthem-Cigna deal
The company says its corporate headquarters will remain in Indianapolis, where its operations are responsible for contributing millions of dollars in corporate taxes and charitable giving.
Health Care & Insurance
Articles
VA secretary optimistic Congress will plug budget gap
During a visit to the Richard L. Roudebush VA Medical Center in Indianapolis, Robert McDonald said Thursday he thinks Congress will act to avoid shutting down some VA hospitals and other cost-cutting steps.
Anthem to buy Cigna in $54B deal
After a long and stormy courtship, Anthem Inc. announced Friday morning that it will pay $188 per share to acquire Cigna Corp., valuing the deal at $54.2 billion in cash, stock and the assumption of debt.
Lilly, Anthem show high risk, high reward strategy can pay off
The CEOs of Eli Lilly and Anthem are being rewarded by investors for taking high-risk approaches to develop breakthrough drugs, make major acquisitions.
Indy’s top 11 acquisition deals, before Anthem-Cigna
Anthem’s $54 billion bid for rival insurer Cigna is twice the size of the next-largest acquisition in the Indianapolis area, which occurred nearly a decade ago.
Investors still cautious about antitrust scrutiny on Anthem-Cigna deal
The stock price for Cigna Corp. remained lethargic during trading Thursday, as another mega-merger of insurers complicated the Anthem deal and sparked antitrust concerns.
Lilly posts lackluster profit but boosts full-year forecast
Eli Lilly and Co.’s profits plunged 18 percent in the second-quarter but still easily beat the lowered expectations of Wall Street analysts.
Alzheimer’s trials offer little certainty for investors, patients
Shares of Eli Lilly and Co. stagnated in Wednesday morning trading as investors and patients wished that the effects of solanezumab were more pronounced. Rival Biogen offered muddy results from its own Alzheimer’s drug.
Indy-area woman charged with faking nursing license, cancer
Ashley Trent faces charges of forgery, deception, theft and practicing nursing without a license. She also is accused of forging letters from IU Health that claimed she had breast cancer.
Report ranks Indiana 32nd for child well-being
The national report found that more Indiana children have health insurance and fewer are abusing drugs and alcohol, but the state still dropped in the rankings due to improved results in other states.
Indy-based health data firm snares $1.5M in VC round
Healthiest Employers LLC, which collects and measures corporate health information, plans to use the funds to drive sales of its analytics software.
Cook Pharmica to hire 70 workers to expand drug-making capacity
Cook Pharmica, a subsidiary of Bloomington-based medical device maker Cook Group, currently employs 575 workers who manufacture and package drugs for use in clinical trials or for sale on the market.
UPDATE: Pence, other governors order Planned Parenthood probes
Gov. Mike Pence has directed the Indiana Department of Health to investigate whether organs from aborted fetuses are being sold.
Lilly partner Immunocore raises record $320 million
Immunocore Ltd., which this week achieved the biggest private fundraising by a European biotechnology firm in 10 years, plans to accelerate development of its cancer therapy using the money and seek expedited approval.
Health care industry: Healthy Indiana Plan working smoothly
State enrollment in HIP 2.0 has climbed to nearly 290,000 participants, with about 60 percent of those people under age 40, according to state figures presented Thursday.
Indiana relaxes bird show ban imposed due to avian flu
Indiana officials who imposed a statewide ban on bird shows have dialed back the emergency rule, but the ban will still keep chickens, ducks and other birds out of August’s Indiana State Fair.
After silence, IU Health and Anthem voice concerns over Chamber’s smoking scandal
With Anthem and IU Health so hot to trot their anti-smoking bona fides, it’s surprising their responses to The New York Times' stories about the U.S. Chamber of Commerce blocking anti-smoking policies overseas have been so tepid.
Lilly, partner sue Lupin over generic testosterone
Indianapolis-based Eli Lilly and Co. and Acrux DDS Pty Ltd. have filed a lawsuit against Lupin Pharmaceuticals Inc. for alleged infringement of patents that cover the testosterone treatment Axiron.
Clot risk in Lilly lung-cancer drug raises FDA concerns
The drug, known as necitumumab, improved patients’ overall chances of survival, yet people taking the medicine also experienced more risk, Food and Drug Administration staff said in a report Tuesday.
Obamacare shovels another $122M to Indiana insurers
The money, known as reinsurance payments, helped MDwise, Anthem, Humana, Assurant and the Physicians Health Plan of Northern Indiana keep a lid on their losses even as lots of new patients with expensive or untreated medical conditions migrated into the private insurance market.